Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited)

v3.21.1
Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-controlling Interest [Member]
Total
Balance at Dec. 31, 2019 $ 2,296 $ 41 $ 47,554 $ (53,715) $ (814) $ (4,638)
Balance, shares at Dec. 31, 2019 1,158,209 40,478,861        
Issue common stock upon partial conversions of Senior Secured Convertible Note $ 2 2,831 2,833
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares 2,042,901        
Series B Convertible Preferred Stock dividends declared $ 69 (69)
Series B Convertible Preferred Stock dividends declared, shares 23,182        
Issue common stock - Employee Stock Purchase Plan 126 126
Issue common stock - Employee Stock Purchase Plan, shares 154,266        
Issue common stock - exercise Series S warrants $ 1 11 12
Issue common stock - exercise Series S warrants, shares 1,199,383        
Issue common stock - conversion Series B Convertible Preferred Stock $ (43) 43
Issue common stock - conversion Series B Convertible Preferred Stock, shares (25,000) 25,000        
Vesting of restricted stock awards
Vesting of restricted stock awards, shares 233,334        
Stock-based compensation - PAVmed Inc. 2014 Equity Plan 328 328
Issue common stock of majority- owned subsidiary exercise of stock options 5 5
Stock-based compensation - majority-owned subsidiary 3 13 16
Loss (14,475) (436) (14,911)
Balance at Mar. 31, 2020 $ 2,322 $ 44 50,896 (68,259) (1,232) (16,229)
Balance, shares at Mar. 31, 2020 1,156,391 44,133,745        
Balance at Dec. 31, 2020 $ 2,537 $ 64 87,570 (88,275) (2,369) (473)
Balance, shares at Dec. 31, 2020 1,228,075 63,819,935        
Issue common stock upon partial conversions of Senior Secured Convertible Note 1,723 1,723
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares 667,668        
Series B Convertible Preferred Stock dividends declared $ 72 (72)
Series B Convertible Preferred Stock dividends declared, shares 24,198        
Issue common stock - Employee Stock Purchase Plan 304 304
Issue common stock - Employee Stock Purchase Plan, shares 203,480        
Issue common stock - conversion Series B Convertible Preferred Stock $ (22) 22
Issue common stock - conversion Series B Convertible Preferred Stock, shares (10,835) 10,835        
Issue common stock - registered offerings, net $ 16 53,688 53,704
Issue common stock - registered offerings, net, shares 15,782,609        
Stock-based compensation - PAVmed Inc. 2014 Equity Plan 631 631
Stock-based compensation - majority-owned subsidiary 3 802 803
Issue common stock - exercise Series Z warrants $ 1 1,375 1,376
Issue common stock - exercise Series Z warrants, shares 860,217        
Issue common stock - PAVmed Inc. 2014 Equity Plan stock option exercises 80 80
Issue common stock - PAVmed Inc. 2014 Equity Plan stock option exercises, shares 80,000        
Loss (9,431) (679) (10,110)
Balance at Mar. 31, 2021 $ 2,587 $ 81 $ 145,396 $ (97,778) $ (2,246) $ 48,040
Balance, shares at Mar. 31, 2021 1,241,438 81,424,744